Defensins -- innate immunity at the epithelial frontier

Area of Science:

• Immunology
• Microbiology
• Molecular Biology

Background:

• The traditional view emphasized physical barriers for mucosal protection against bacteria.
• Recent discoveries reveal specialized antimicrobial peptides (AMPs) play a significant role in mucosal defense.
• AMPs are widespread, conserved across species, and crucial for innate immunity.

Purpose of the Study:

• To investigate the role of epithelial-expressed antimicrobial peptides in mucosal defense.
• To highlight the significance of AMPs as a rapidly acting component of innate immunity.
• To explore the defensin family, a key subgroup of AMPs, and their distribution.

Main Methods:

• Identification and characterization of antimicrobial peptides.
• Analysis of epithelial expression patterns of AMPs.
• Comparative genomics to study conservation across species.

Main Results:

• Over 100 antimicrobial peptides have been identified, with ongoing discoveries.
• Epithelial expression of AMPs is critical, especially where pathogens adhere.
• Defensins (alpha- and beta-) are a major subgroup, with eight identified human variants exhibiting diverse antimicrobial properties.
• Organ-specific expression patterns and homologous peptides found across diverse organisms.

Conclusions:

• Antimicrobial peptides represent a vital, rapidly acting defense system supplementing physical mucosal barriers.
• Defensins are key players in this innate immune response, with broad phylogenetic and organ-specific distribution.
• Further research into epithelial antimicrobial defense, particularly involving alpha-defensins and cryptdins, is warranted.